Therapeutic administration of 131I for differentiated thyroid cancer: Radiation dose to ovaries and outcome of pregnancies

Journal of Nuclear Medicine

Volumn 49, Issue 5, 2008, Pages 845-852

  Garsi, Jérôme Philippe ^a,b,c   Schlumberger, Martin ^b   Rubino, Carole ^a,b,c   Ricard, Marcel ^b   Labbé, Martine ^a,b,c   Ceccarelli, Claudia ^d   Schvartz, Claire ^e   Henri Amar, Michel ^f   Bardet, Stéphane ^f   De Vathaire, Florent ^a,b,c  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITY OF PISA   (Italy)

^e INSTITUT JEAN GODINOT   (France)

^f CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

Differentiated thyroid carcinoma; Ovaries; Pregnancy outcome; Radiation dose; Radioiodine therapy

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CONGENITAL MALFORMATION; DEATH; FEMALE; HUMAN; INCIDENCE; INTERVIEW; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; SPONTANEOUS ABORTION; STILLBIRTH; THYROID CANCER; INDUCED ABORTION; LIVE BIRTH; MIDDLE AGED; OVARY; PREGNANCY; RISK FACTOR; THYROID TUMOR;

ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; LIVE BIRTH; MIDDLE AGED; OVARY; PREGNANCY; PREGNANCY OUTCOME; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RISK FACTORS; STILLBIRTH; THYROID NEOPLASMS;

EID: 44149117258     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.046599     Document Type: Article

References (28)

1. Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med. 1982;23:561-568.
2. Dunn JT. Choice of therapy in young adults with hyperthyroidism of Graves' disease: a brief, case-directed poll of fifty-four thyroidologists. Ann Intern Med. 1984;100:891-893.
3. Loevinger R, Budinger TF, Watson EE. MIRD Primer. Reston, VA: Society of Nuclear Medicine; 1999.
4. Bal C, Kumar A, Tripathi M, et al. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring. Int J Radiat Oncol Biol Phys. 2005;63:449-455.
5. Ehrenheim C, Hauswirth C, Fitschen J, Martin E, Oetting G, Hundeshagen H. Genetic risk after high dose radioiodine therapy with regard to gonadal dose [in German]. Nuklearmedizin. 1997;36:157-166.
6. Schlumberger M, De Vathaire F, Ceccarelli C, et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med. 1996;37:606-612.
7. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060.
8. Classification Internationale Type des Professions. Bureau International du Travail; 1985.
9. Muir C, Waterhouse J, Mack T, Powell J. Cancer Incidence in Five Continents. Lyon, France: IARC; 1987. IARC Scientific Publication No. 88.
10. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol II. The Design and Analysis of Cohort Studies. Lyon, France: IARC; 1987. IARC Scientific Publication No. 82.
11. Sankaranarayana K, Chakraborty R. Ionizing radiation and genetic risks. XI. The doubling dose estimates from the mid-1950s to the present and the conceptual change to the use of human data on spontaneous mutation rates and mouse data on induced mutation rates for doubling dose calculations. Mutat Res. 2000;453:107-127.
12. Schull WJ, Otake M, Neel JV. Genetic effects of the atomic bombs: a reappraisal. Science. 1981;213:1220-1227.
13. Lyon MF. James Neel and the doubling dose concept. Mutat Res. 2003;543:115-120.
14. Nomura T. Transgenerational carcinogenesis: induction and transmission of genetic alterations and mechanisms of carcinogenesis. Mutat Res. 2003;544:425-432.
15. Neel JV, Schull WJ, Awa AA, et al. The children of parents exposed to atomic bombs: estimates of the genetic doubling dose of radiation for humans. Am J Hum Genet. 1990;46:1053-1072.
16. Neel JV, Lewis SE. The comparative radiation genetics of humans and mice. Annu Rev Genet. 1990;24:327-362.
17. Otake M, Schull WJ, Neel JV. Congenital malformations, stillbirths, and early mortality among the children of atomic bomb survivors: a reanalysis. Radiat Res. 1990;122:1-11.
18. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002;187:1070-1080.
19. Grosche B, Irl C, Schoetzau A, van Santen E. Perinatal mortality in Bavaria, Germany, after the Chernobyl reactor accident. Radiat Environ Biophys. 1997;36:129-136.
20. Scherb H, Weigelt E, Bruske-Hohlfeld I. European stillbirth proportions before and after the Chernobyl accident. Int J Epidemiol. 1999;28:932-940.
21. Scherb H, Weigelt E, Bruske-Hohlfeld I. Regression analysis of time trends in perinatal mortality in Germany 1980-1993. Environ Health Perspect. 2000;108:159-165.
22. Auvinen A, Vahteristo M, Arvela H, et al. Chernobyl fallout and outcome of pregnancy in Finland. Environ Health Perspect. 2001;109:179-185.
23. Ericson A, Kallen B. Pregnancy outcome in Sweden after the Chernobyl accident. Environ Res. 1994;67:149-159.
24. Irgens LM, Lie RT, Ulstein M, et al. Pregnancy outcome in Norway after Chernobyl. Biomed Pharmacother. 1991;45:233-241.
25. Izumi S, Suyama A, Koyama K. Radiation-related mortality among offspring of atomic bomb survivors: a half-century of follow-up. Int J Cancer. 2003;107:292-297.
26. Izumi S, Koyama K, Soda M, Suyama A. Cancer incidence in children and young adults did not increase relative to parental exposure to atomic bombs. Br J Cancer. 2003;89:1709-1713.
27. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer. 2002;99:260-266.
28. LaFranchi SH, Haddow JE, Hollowell JG. Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? Thyroid. 2005;15:60-71.